Literature DB >> 28839688

The future developments in upper GI cancer.

Hugh Barr1, Max Almond2.   

Abstract

The ageing population and changes in incidence of upper gastrointestinal cancer will have profound changes for our management of these patients. There is much debate as how to bring forward the diagnosis of early mucosal cancer that may be curable using endoscopy or by surgery. In the older more frail patients, early disease will often be controlled by endoscopic resection and ablation therapy.

Entities:  

Year:  2012        PMID: 28839688      PMCID: PMC5551947          DOI: 10.1136/flgastro-2012-100113

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  21 in total

1.  Esophageal adenocarcinoma incidence: are we reaching the peak?

Authors:  Heiko Pohl; Brenda Sirovich; H Gilbert Welch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

Review 2.  Endoscopic work-up of early Barrett's neoplasia.

Authors:  W L Curvers; A Bansal; P Sharma; J J Bergman
Journal:  Endoscopy       Date:  2008-12-08       Impact factor: 10.093

3.  Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study.

Authors:  H Watabe; T Mitsushima; Y Yamaji; M Okamoto; R Wada; T Kokubo; H Doi; H Yoshida; T Kawabe; M Omata
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

4.  Improving surveillance for Barrett's oesophagus.

Authors:  Peter A Bampton; Anne Schloithe; Jeff Bull; Robert J Fraser; Rob T A Padbury; David I Watson
Journal:  BMJ       Date:  2006-06-03

Review 5.  The Japanese guidelines for gastric cancer screening.

Authors:  Chisato Hamashima; Daisuke Shibuya; Hideo Yamazaki; Kazuhiko Inoue; Akira Fukao; Hiroshi Saito; Tomotaka Sobue
Journal:  Jpn J Clin Oncol       Date:  2008-03-14       Impact factor: 3.019

6.  Screening for gastric cancer in Korea: population-based preferences for endoscopy versus upper gastrointestinal series.

Authors:  Kui Son Choi; Min-Son Kwak; Hoo-Yeon Lee; Jae Kwan Jun; Myung-Il Hahm; Eun-Cheol Park
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-04-21       Impact factor: 4.254

7.  Radiofrequency ablation in Barrett's esophagus with dysplasia.

Authors:  Nicholas J Shaheen; Prateek Sharma; Bergein F Overholt; Herbert C Wolfsen; Richard E Sampliner; Kenneth K Wang; Joseph A Galanko; Mary P Bronner; John R Goldblum; Ana E Bennett; Blair A Jobe; Glenn M Eisen; M Brian Fennerty; John G Hunter; David E Fleischer; Virender K Sharma; Robert H Hawes; Brenda J Hoffman; Richard I Rothstein; Stuart R Gordon; Hiroshi Mashimo; Kenneth J Chang; V Raman Muthusamy; Steven A Edmundowicz; Stuart J Spechler; Ali A Siddiqui; Rhonda F Souza; Anthony Infantolino; Gary W Falk; Michael B Kimmey; Ryan D Madanick; Amitabh Chak; Charles J Lightdale
Journal:  N Engl J Med       Date:  2009-05-28       Impact factor: 91.245

8.  Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

Authors:  Peter M Rothwell; F Gerald R Fowkes; Jill F F Belch; Hisao Ogawa; Charles P Warlow; Tom W Meade
Journal:  Lancet       Date:  2010-12-06       Impact factor: 79.321

9.  Improving surveillance for Barrett's oesophagus: AspECT and BOSS trials provide an evidence base.

Authors:  Janusz Jankowski; Hugh Barr
Journal:  BMJ       Date:  2006-06-24

10.  Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.

Authors:  Rebecca C Fitzgerald; Richard Hardwick; David Huntsman; Fatima Carneiro; Parry Guilford; Vanessa Blair; Daniel C Chung; Jeff Norton; Krishnadath Ragunath; J Han Van Krieken; Sarah Dwerryhouse; Carlos Caldas
Journal:  J Med Genet       Date:  2010-07       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.